Effect of introducing the non-invasive blood glucose intelligent device in the management of community patients with type 2 diabetes mellitus
Objective:To understand the effect of introducing the non-invasive blood glucose intelligent device with real-time clinicians'supervision and guidance towards the management of the patients with diabetes mellitus.Methods:In May 2020,68 patients with type 2 diabetes in Meilong Community in Shanghai who were eligible based on the inclusion criteria were intervened and followed up for three months.Among them there were 31 males and the average age was(73.71±5.89)years;there were 37 females,and the average age was(71.78±4.62)years.During the research process,the demographic characteristics and clinical characteristics were collected from these patients.Glycated hemoglobin(HbA1c),fasting blood glucose(FBG),body weight and blood pressure were compared before and after the intervention.Results:The average HbA1c was(6.93%±1.25)%and FBG(5.71±1.28)mmol/L of the patients before the intervention.After intervention,the levels of HbA1c and body weight decreased by 0.35%and 0.45 kg,respectively,and the difference was statistically significant(P<0.05),and there was no statistically significant difference in FBG level,systolic and diastolic blood pressures(P<0.05).Conclusion:Introducing the non-invasive blood glucose intelligent device with real-time clinicians'supervision and guidance can effectively control the prognosis of patients with type 2 diabetes mellitus in the community.
type 2 diabetes mellitusnon-invasive blood glucose intelligent devicecommunity management
NETL
NSTL
万方数据
